HK1222584A1 - 包含细菌混合物的组合物及用於降低酒精的影响的方法，该细菌混合物包含片球菌和乳酸菌 - Google Patents

包含细菌混合物的组合物及用於降低酒精的影响的方法，该细菌混合物包含片球菌和乳酸菌 Download PDF

Info

Publication number
HK1222584A1
HK1222584A1 HK16110906.4A HK16110906A HK1222584A1 HK 1222584 A1 HK1222584 A1 HK 1222584A1 HK 16110906 A HK16110906 A HK 16110906A HK 1222584 A1 HK1222584 A1 HK 1222584A1
Authority
HK
Hong Kong
Prior art keywords
pedoiococcus
lactobacillus
bacteria
alcohols
decreasing
Prior art date
Application number
HK16110906.4A
Other languages
English (en)
Chinese (zh)
Inventor
Richard. CARPENTER
Amit. KAPUR
Narayan. SURESH
E. Wesley. HUFF
Original Assignee
BiOWiSH Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BiOWiSH Technologies, Inc. filed Critical BiOWiSH Technologies, Inc.
Publication of HK1222584A1 publication Critical patent/HK1222584A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
HK16110906.4A 2013-05-10 2014-05-12 包含细菌混合物的组合物及用於降低酒精的影响的方法，该细菌混合物包含片球菌和乳酸菌 HK1222584A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361821974P 2013-05-10 2013-05-10
US61/821,974 2013-05-10
PCT/US2014/037704 WO2014183117A1 (en) 2013-05-10 2014-05-12 Compositions comprising a mixture of bacteria comprising pedoiococcus and lactobacillus an methods for decreasing the effects of alcohols

Publications (1)

Publication Number Publication Date
HK1222584A1 true HK1222584A1 (zh) 2017-07-07

Family

ID=50980375

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16110906.4A HK1222584A1 (zh) 2013-05-10 2014-05-12 包含细菌混合物的组合物及用於降低酒精的影响的方法，该细菌混合物包含片球菌和乳酸菌

Country Status (10)

Country Link
US (1) US10130664B2 (cg-RX-API-DMAC7.html)
EP (1) EP2994149A1 (cg-RX-API-DMAC7.html)
JP (1) JP6452258B2 (cg-RX-API-DMAC7.html)
KR (1) KR20160013069A (cg-RX-API-DMAC7.html)
CN (1) CN106456679A (cg-RX-API-DMAC7.html)
AU (2) AU2014262427B2 (cg-RX-API-DMAC7.html)
CA (1) CA2911947A1 (cg-RX-API-DMAC7.html)
HK (1) HK1222584A1 (cg-RX-API-DMAC7.html)
RU (1) RU2671221C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014183117A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170005093A (ko) 2014-05-12 2017-01-11 바이오위시 테크놀로지스, 인크. 인간 건강 및 영양 향상을 위한 조성물 및 방법
KR101853603B1 (ko) * 2017-05-18 2018-05-02 주식회사 쎌바이오텍 알코올 또는 아세트알데하이드 분해용 프로바이오틱스를 포함하는 조성물
WO2019232026A1 (en) 2018-05-29 2019-12-05 BiOWiSH Technologies, Inc. Compositions and methods for improving survivability of aquatic animals
CN109350629B (zh) * 2018-08-09 2021-06-01 新乡医学院 一种用于治疗酒精戒断综合征的益生菌复合制剂及其制备方法
CN115919907A (zh) * 2021-08-31 2023-04-07 E·施约林 一种用于治疗和/或预防食物和/或酒精中毒的组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998007867A2 (en) * 1996-08-22 1998-02-26 Bioteknologisk Institut Metabolically engineered lactic acid bacteria and means for providing same
US6953574B2 (en) * 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
CN1993052B (zh) * 2004-07-29 2011-08-17 京都府 植物病害防除剂和防除方法
FR2881751B1 (fr) * 2005-02-07 2007-04-27 Virbac Sa Sa Compositions comprenant des micro-organismes deshydrates, leurs procedes de preparation, et leurs utilisations
KR100661032B1 (ko) * 2005-04-19 2006-12-22 주식회사한국야쿠르트 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물
US20060263385A1 (en) 2005-05-17 2006-11-23 Fran Gare Composition to relieve side effects of alcohol intoxication
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
IT1392101B1 (it) 2008-12-12 2012-02-09 Zuccari Societa A Responsabilita Limitata In Breve Zuccari S R L Composizione comprendente isoflavoni
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
US9161957B2 (en) 2012-08-03 2015-10-20 Life Well Lived, Llc Compositions and methods for reducing blood alcohol content
CN104755092A (zh) * 2012-10-30 2015-07-01 雀巢产品技术援助有限公司 用于递送协同免疫作用的包含微粒和益生菌的组合物
CN102934809B (zh) * 2012-12-10 2014-04-30 济南大学 益生菌发酵中药制剂制备的组合物及其制备方法和应用

Also Published As

Publication number Publication date
US10130664B2 (en) 2018-11-20
CN106456679A (zh) 2017-02-22
EP2994149A1 (en) 2016-03-16
AU2014262427B2 (en) 2018-12-13
CA2911947A1 (en) 2014-11-13
AU2014262427A1 (en) 2015-11-26
AU2019201637A1 (en) 2019-04-11
RU2015152826A (ru) 2017-06-20
RU2671221C2 (ru) 2018-10-30
JP2016521287A (ja) 2016-07-21
KR20160013069A (ko) 2016-02-03
JP6452258B2 (ja) 2019-01-16
US20140335187A1 (en) 2014-11-13
WO2014183117A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
AU2016202480A1 (en) Seed-origin endophyte populations, compositions, and methods of use
EP3191584A4 (en) Methods of producing mogrosides and compositions comprising same and uses thereof
EP3102681A4 (en) Trifunctional t cell-antigen coupler and methods and uses thereof
EP2991658A4 (en) Antimicrobial compositions and methods of making the same
EP2981166A4 (en) Methods and compositions for integration of an exogenous sequence within the genome of plants
EP2953472A4 (en) Synergistic bacterial compositions and methods of production and use thereof
WO2014113729A8 (en) Methods of treating cholangiocarcinoma
IN2015DN00127A (cg-RX-API-DMAC7.html)
MX2013008390A (es) Preparacion de estructuras de metal-triazolato.
HK1198689A1 (en) Antibody formulations and methods
ZA201508529B (en) Bacterial fermentation methods and compositions
EP2965347A4 (en) Ion implantation compositions, systems, and methods
EP3033351A4 (en) Antiviral methods and compositions comprising probiotic bacterial molecules
EP3003297A4 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
EP3049066A4 (en) Compositions and methods for the manufacture of lipid nanoparticles
EP3046581A4 (en) Compositions and methods for treatment of hsct-associated thrombotic microangiopathy
EP3013364A4 (en) Tuberculosis compositions and methods of using the same
EP3043811A4 (en) Compositions and methods for the delivery of molecules into live cells
WO2016001885A3 (en) Amorphous form of eliglustat hemitartarate
EP3013855A4 (en) Mutant factor viii compositions and methods
HK1222584A1 (zh) 包含细菌混合物的组合物及用於降低酒精的影响的方法，该细菌混合物包含片球菌和乳酸菌
EP3165599A4 (en) Novel lactic acid bacterium and composition including said lactic acid bacterium
WO2014146111A3 (en) Analgesic compounds and methods of use
EP3057579A4 (en) Carbohydrate-containing dietary compositions and methods for their preparation and use
IN2014DN06617A (cg-RX-API-DMAC7.html)